Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cost of gleevec 400 mg?When was alphagan p approved?Pimozide investigational drug company alpha 2 agonists?Blinatumomab biosimilar in development?What alcohol amounts affect lipitor's cholesterol lowering therapy?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its FDA approval in 2014 [1].
The initial FDA approval is dated to 2014, and the drug later gained additional approvals for other cancer types and settings as new clinical data were reviewed [1].
Other Questions About Keytruda :